Brook StarRay Wireless Controller Now Available — Native PS5 Support Meets Xbox-Style Control
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Scalare Launches EquityRoom, Adding a Subscription Revenue Stream to Its Founder Ecosystem
Megaannum Capital and Zhongke Xianxing Venture Capital Enter into Strategic Partnership
Airtripmaker Expands Business and First-class Flights Network to London, Amsterdam, Frankfurt, Tokyo, Sydney by Introducing Enhanced Coverage for Global Destinations as Part of Its Ongoing Growth Strategy
PALO ALTO, Calif., May 15, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
U.S. FDA granted Fast Track designation for 177Lu-PNT2002 for the treatment of mCRPC in April…
― Appointed Alex C. Sapir CEO & President, effective July 1st, 2023 ― ― On…
~ uniQure to receive $375 million upfront cash payment ~ ~ Under the existing agreement…
WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:…
OTL-200 Biologics License Application (BLA) submission completion anticipated in mid-2023 Libmeldy revenue and commercial patients…
BOCA RATON, Fla., May 15, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ: FWBI)…
— Industry veteran brings more than 20 years of experience; will assume role effective July…
OLINVYK receives regulatory approval in China, triggering $3 million milestone payment from Company’s China partner…
Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with…
Two ongoing Phase 2 studies of bitopertin in EPP; initial safety and efficacy data from…
Safety data indicate that repeated subcutaneous injections of 25 mg CTI-1601 were generally well tolerated…
Oxford Biomedica launches TetraVectaTM – the next generation lentiviral vector system Oxford, UK – 15…
PRESS RELEASE Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer Arun is an award-winning…
— Results from Cohort D, an expansion cohort of type 2 diabetic, pre-cirrhotic NASH patients…
Presenting longer-term follow-up data from investigator-initiated trial (IIT) evaluating BCMA/CD19 dual-targeting FasTCAR-T GC012F in relapsed/refractory…
WESTLAKE VILLAGE, Calif., May 15, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage…
First study comparing blockade of the IL-4 receptor and IL-13 receptor, both components of the…
Castellum, Inc. Announces First Quarter Financial Results and Provides Forward Guidance Revenues for the three…
– Continued progress toward PDUFA goal date of January 5, 2024, for berdazimer gel, 10.3%…